What's new

Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 16, Status: Authorised

Mar 26, 2025 - 17:13
 0
Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 16, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Columvi, glofitamab, D...

Next Article

8 Tips On How To Clean Your House for the Spring

Related Posts

European Shortages Monitoring Platform (ESMP) data acce...

Mar 10, 2025  0

Training on human variations web-based electronic application form (eAF) functionalities for CAPs and non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 27 February 2025, 10:30 (CET) to 27 February 2025, 12:30 (CET)

Training on human variations web-based electronic appli...

Feb 21, 2025  0

Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 12, 2025  0